A treatment system that uses steam to ablate prostate tissue (Rezūm, NxThera, Inc.) can be considered as a first-line therapy for the treatment of lower urinary tract symptoms secondary to BPH, say investigators from a non-randomized multicenter pilot study with 2-year duration of successful outcomes.
Other basic science research pearls include preliminary evidence from a porcine model suggesting botulinum toxin type A facilitates ureteral stone passage and the identification of two different microdeletions in the NELL1 gene on chromosome 11 in men with Peyronie's disease.
Expression of androgen receptor splice variant 7 (AR-V7) in whole blood predicts worse cancer-related outcomes in patients with metastatic castration-resistant prostate cancer who are treated with abiraterone acetate (ZYTIGA).
An image-guided technique for treating LUTS associated with BPH is reproducible and promising, researchers say.
In a head-to-head comparison, sunitinib (Sutent) prolonged radiographic progression-free survival compared with everolimus (Afinitor), but with greater toxicity, in patients with specific subtypes of metastatic renal cell carcinoma and non-clear cell histology, said Andrew J. Armstrong, MD, MSc.
An increasing proportion of certifying and recertifying urologists are women, and they perform a disproportionate volume of female urology cases, researchers at Northwestern University in Chicago found.
Two-thirds of patients attending a urology clinic for the management of urolithiasis failed to meet physical activity guidelines. In addition, patients with recent symptomatic urolithiasis were significantly more likely to be current smokers than those without recent symptomatic urolithiasis, according to a recent study.
The authors sought to identify factors associated with 30-day emergency department visits and readmission following URSLL.
A handheld transurethral therapy that delivers targeted sterile water vapor reduces lower urinary tract symptom severity in patients with BPH with no impact on sexual function.
A large, randomized trial provides a head-to-head comparison of late complications involving the two approaches to BPH.